Author

Julie Wells

Observed name: J. Wells

Institution: Ottawa Hospital Research Institute

Observed institutions: University Health Network, The University of Texas MD Anderson Cancer Center, University of Ottawa, University of Toronto, Ottawa Hospital, Toronto General Hospital, Princess Margaret Cancer Centre, Kirkland and District Hospital, Ottawa Hospital Research Institute, Canadian Cancer Trials Group, McMaster University

OpenAlex ID: A5089147705

A Phase I study of olaparib and irinotecan in patients with colorectal cancer: Canadian Cancer Trials Group IND 187

2016 · Eric X. Chen, Derek J. Jonker, et al. · Investigational New Drugs · 55

Phase I Clinical Trial of Exherin (ADH-1) in Patients with Advanced Solid Tumors

2013 · Nirit Yarom, David Stewart, et al. · Current Clinical Pharmacology · 39

Phase I Study of Cediranib in Combination with Oxaliplatin and Infusional 5-Fluorouracil in Patients with Advanced Colorectal Cancer

2009 · Eric Chen, Derek Jonker, et al. · Clinical Cancer Research · 37

Phase I study of oncolytic virus (OV) MG1 maraba/MAGE-A3 (MG1MA3), with and without transgenic MAGE-A3 adenovirus vaccine (AdMA3) in incurable advanced/metastatic MAGE-A3-expressing solid tumours: CCTG IND.214.

2017 · Derek J. Jonker, Sebastien J. Hotte, et al. · Journal of Clinical Oncology · 21

Final clinical and pharmacokinetic (PK) results from a phase 1 study of the novel N-cadherin (N-cad) antagonist, Exherin (ADH-1), in patients with refractory solid tumors stratified according to N-cad expression

2006 · D. J. Stewart, D. J. Jonker, et al. · Journal of Clinical Oncology · 14

Adjuvant sunitinib following chemoradiotherapy and surgery for locally advanced esophageal cancer: a phase II trial

2015 · A. M Horgan, G. Darling, et al. · Diseases of the Esophagus · 13

ADH-1 in the treatment of metastatic adrenocortical carcinoma--case report.

2011 · Nirit Yarom, David Stewart, et al. · PubMed · 7

Adjuvant sunitinib (Su) for locally advanced esophageal cancer (LAEC): Results of a phase II trial.

2011 · J. J. Knox, R. Wong, et al. · Journal of Clinical Oncology · 6

A phase I study of the novel molecularly targeted vascular targeting agent, Exherin (ADH-1), shows activity in some patients with refractory solid tumors stratified according to N-cadherin expression

2005 · D. J. Jonker, D. J. Stewart, et al. · Journal of Clinical Oncology · 6

Immunotherapy for persisting viral infection and associated cancer

2016 · Ian H. Frazer, Stephen R. Mattarollo, et al. · European Journal of Immunology

Works count: 10

Citation count: 198

H-index: 7

I10-index: 6